Delayed methotrexate start improves pneumococcal vaccine response in rheumatoid arthritis
WASHINGTON — Delaying methotrexate initiation for 1 month after pneumococcal vaccination improves humoral response in patients with rheumatoid arthritis, according to data presented at ACR Convergence 2024. “As you know, vaccination against pneumococcus is recommended in patients with RA being treated with methotrexate,” Jacques Morel, MD, of the University Hospital of